ZHEJIANG HUAKANG PHARMACEUTICAL CO.,LTD. – Trademark Portfolio
Entity Type: 03
ZHEJIANG HUAKANG PHARMACEUTICAL CO.,LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include HEGAN.
No.18, Huagong Road, Huabu Town,
Kaihua County, Quzhou City 324302 Zhejia
Showing of trademarks Trademarks
Trademark Classifications
ZHEJIANG HUAKANG PHARMACEUTICAL CO.,LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does ZHEJIANG HUAKANG PHARMACEUTICAL CO.,LTD. have?
ZHEJIANG HUAKANG PHARMACEUTICAL CO.,LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does ZHEJIANG HUAKANG PHARMACEUTICAL CO.,LTD. file in?
ZHEJIANG HUAKANG PHARMACEUTICAL CO.,LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 30 (Staple Foods). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are ZHEJIANG HUAKANG PHARMACEUTICAL CO.,LTD.'s most well-known trademarks?
ZHEJIANG HUAKANG PHARMACEUTICAL CO.,LTD.'s registered trademark portfolio includes well-known marks such as HEGAN. These are among 1 currently registered trademark in the portfolio.
What is ZHEJIANG HUAKANG PHARMACEUTICAL CO.,LTD.'s trademark registration success rate?
ZHEJIANG HUAKANG PHARMACEUTICAL CO.,LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.